Cortecs Closer To Osteoporosis Kit

12 February 1996

Cortecs International has developed a working prototype of its candidate osteoporosis kit, which detects collagen breakdown in whole blood. This is the first major milestone for the project and demonstrates the feasibility of combining Cortecs' point-of-care diagnostics technology with the bone marker technology developed by partner Osteometer BioTech. Osteometer's Cross Laps technology was found to be the most accurate predictor of hip fracture, after correction of variables, out of five candidate osteoporosis markers tested in the recent EPIDOS study.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight